| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 315,8 k € | +1.0% | 312,7 k € | -25.9% | 422,0 k € | +241.7% | 123,5 k € | -20.1% | 154,6 k € | +5.2% | 146,9 k € | +14.8% | 127,9 k € | -33.1% | 191,1 k € | +20.1% | 159,2 k € | -9.5% | 176,0 k € | +57.5% | 111,7 k € | +34.7% | 82,9 k € | +20.8% | 68,7 k € | +943.0% | -8,1 k € | -106.0% | 136,5 k € | +8.2% | 126,1 k € | -24.6% | 167,2 k € | -48.8% | 326,3 k € | +39.2% | 234,5 k € | |
| EBITDA | 314,2 k € | +1.0% | 311,1 k € | -26.0% | 420,6 k € | +244.4% | 122,1 k € | -20.3% | 153,2 k € | +5.5% | 145,2 k € | +16.2% | 125,0 k € | -34.2% | 190,0 k € | +23.5% | 153,9 k € | -11.8% | 174,4 k € | +58.1% | 110,3 k € | +35.7% | 81,3 k € | +22.2% | 66,5 k € | +578.8% | -13,9 k € | -110.6% | 131,6 k € | +8.8% | 120,9 k € | -24.7% | 160,6 k € | -50.3% | 323,1 k € | +39.7% | 231,3 k € | |
| Operating profit | 312,3 k € | +0.7% | 310,0 k € | -25.0% | 413,3 k € | +259.7% | 114,9 k € | -21.4% | 146,1 k € | +5.8% | 138,2 k € | +17.1% | 117,9 k € | -37.6% | 188,9 k € | +24.2% | 152,1 k € | -11.4% | 171,7 k € | +61.9% | 106,1 k € | +44.7% | 73,3 k € | +23.0% | 59,6 k € | +400.7% | -19,8 k € | -115.7% | 126,5 k € | +10.8% | 114,2 k € | -19.8% | 142,4 k € | -53.8% | 308,5 k € | +44.4% | 213,7 k € | |
| Profit/loss | 211,9 k € | +1.4% | 209,0 k € | -25.7% | 281,4 k € | +259.7% | 78,2 k € | -21.3% | 99,3 k € | +55.3% | 64,0 k € | -23.2% | 83,3 k € | -37.4% | 133,1 k € | +30.1% | 102,3 k € | -15.3% | 120,8 k € | +30.3% | 92,7 k € | +19.9% | 77,3 k € | +8.7% | 71,1 k € | +1377.2% | 4,8 k € | -95.5% | 106,9 k € | +4.0% | 102,8 k € | +0.8% | 102,0 k € | -44.0% | 182,0 k € | +5.4% | 172,7 k € | |
| Equity | 1,6 M € | +14.9% | 1,4 M € | +17.2% | 1,2 M € | +30.2% | 932,2 k € | +9.2% | 854,0 k € | +13.2% | 754,7 k € | +9.3% | 690,8 k € | -64.7% | 2,0 M € | +7.3% | 1,8 M € | +5.9% | 1,7 M € | +7.5% | 1,6 M € | +909.5% | 158,6 k € | -90.0% | 1,6 M € | +4.7% | 1,5 M € | +0.3% | 1,5 M € | +7.6% | 1,4 M € | +7.9% | 1,3 M € | +8.5% | 1,2 M € | +18.0% | 1,0 M € | |
| Total assets | 1,8 M € | +5.0% | 1,7 M € | +3.0% | 1,6 M € | +12.8% | 1,4 M € | +1.9% | 1,4 M € | +3.1% | 1,4 M € | -0.2% | 1,4 M € | -34.3% | 2,1 M € | +7.9% | 1,9 M € | +1.2% | 1,9 M € | +10.6% | 1,7 M € | +0.6% | 1,7 M € | +3.5% | 1,7 M € | +8.5% | 1,5 M € | +0.3% | 1,5 M € | +6.4% | 1,4 M € | +7.2% | 1,3 M € | +1.4% | 1,3 M € | +15.4% | 1,1 M € | |
| Cash | 621,4 k € | +18.5% | 524,2 k € | +7.9% | 485,8 k € | +67.6% | 289,8 k € | +6.1% | 273,0 k € | +27.0% | 215,0 k € | -3.8% | 223,5 k € | +121.2% | 101,0 k € | +4.9% | 96,3 k € | -29.0% | 135,7 k € | -44.6% | 244,7 k € | -18.2% | 299,3 k € | +21.3% | 246,9 k € | -3.4% | 255,6 k € | +117.9% | 117,3 k € | -21.5% | 149,4 k € | -6.4% | 159,6 k € | +26.9% | 125,8 k € | -7.4% | 135,8 k € | |
| Debts | 128,2 k € | -49.9% | 256,0 k € | -38.6% | 416,6 k € | -18.2% | 509,4 k € | -9.8% | 564,5 k € | -9.1% | 620,8 k € | -9.7% | 687,8 k € | +403.2% | 136,7 k € | +24.4% | 109,9 k € | -20.5% | 138,2 k € | +71.0% | 80,8 k € | -94.7% | 1,5 M € | +5636.9% | 26,6 k € | +0.3% | 26,5 k € | -3.1% | 27,4 k € | -34.8% | 42,0 k € | -11.8% | 47,6 k € | -63.4% | 130,1 k € | -3.7% | 135,1 k € | |
Private limited company · Antwerpen · incorporated on 14/10/1992
Private limited company profitable and well capitalised. Cash position rising (+18.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Noorman van der Dussen is a Private limited company incorporated in 1992. Its main activity is: Hospital activities. Its registered office is in Antwerpen.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette